Wednesday, October 09, 2013 2:56:55 PM
"These higher doses will increase the interactions of endogenous entities (such as immunomodulators like IgG) with the sialic acid mimics on the nanoviricides, reducing the availability of these necessary constituents for normal biochemical interactions."
My first concern you described pretty well above. The sialic acid receptors on cells have many normal biological functions. These normal functions could be disrupted by bombarding the body with nanoviricide cell-mimics (extra sialic acid receptors that are mere decoys), such that the normal biological function interacting with the cell's sialic acid receptors may be altered or reduced.
There is a whole host of immune related cells that bind to sialic acid receptors, using any of a family of proteins on their cell surface called SIGLECs (sSialic acid-binding immunoglobulin-type lectins):
http://en.wikipedia.org/wiki/SIGLEC
"The primary function of Siglecs is to bind glycans containing sialic acids. These receptor-glycan interactions can be used in cell adhesion, cell signalling and others."
Here is one example of how the body uses sialic acid receptor, in fact this paper characterizes human SIGLEC-1, sialoadhesin:
http://bloodjournal.hematologylibrary.org/content/97/1/288.short
Macrophages express sialoadhesin molecules that bind to sialic acid receptors on bone marrow hemopoietic cells. So maybe now the macrophages bind to FluCide and don't perform their normal function as well, causing problems in red blood cell production, for instance.
The paper showed the mouse version of sialoadhesin was very similar to the human version. I hope and am pretty confident that all the mouse and other animal studies showing low toxicity will translate into humans.
The second possible concern I have is some kind of immune reaction against the nanoviricides. This is less likely using the PEG backbone, but still a possibility. What if the body started to recognize sialic acid (from the FluCide) as a foreign substance / invader, and the body started to attack all those cells with that receptor?
It's great that nanoviricides are *theoretically* non-toxic, host agnostic, and don't enter into cells, but you never know for sure. There certainly will be SOME host interaction, thus the need to do tox and human testing. I'm betting the interaction / disruption of host biochemical processes will be small, but will feel much better when this is definitively proven.
Recent NNVC News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/15/2024 08:44:44 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/27/2024 08:15:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM